Costa Rica Authorizes Oral Covid-19 Medication

Read Time:46 Seconds

The Ministry of Health has notified the company Merck Sharp & Dohme Corp of the emergency use authorization for the drug Molnupiravir 200 mg capsules, which enables the company to sell it nationwide in Costa Rica.

The Ministry of Health released a statement saying “Molnupiravir is indicated for the treatment of mild to moderate COVID-19 disease in adults with positive direct viral test results for SARS-CoV-2 and who are at high risk of progression to severe COVID-19, including hospitalizations. or death.

The use authorization is provided based on the Administrative Resolution MS-DM-RM-1363-2022 published on January 24 of this year, which establishes the requirements to obtain an Authorization for the Use and Import of medicines to treat Covid-19, based on the recognition of the Marketing Authorization or Emergency Use Authorization of Strict Regulatory Authorities or of medicines recommended by the World Health Organization.

Source: Tico Times

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
106460cookie-checkCosta Rica Authorizes Oral Covid-19 Medication